RALOX as Second Line Treatment for Advanced Malignant Biliary System Tumor
Clinical trial NCT05148143 · UNKNOWN
Trial details
- NCT number
- NCT05148143
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-01
- Primary completion
- 2022-12-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.